About ALX Oncology

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
Biotechnology
Location
Location
323 Allerton Ave,South San Francisco,California,US
Description
Information
Alexo Therapeutics is a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint mechanism exploited by cancer cells to evade the immune system. Our lead candidate, ALX148, is a fusion protein that comprises an engineered high affinity CD47 binding domain of SIRPa linked to an inactive Fc region of human immunoglobulin. ALX148 is designed to enhance the efficacy of antibody-based therapies and is in clinical development for a broad range of tumor types. For more information about the company, please visit our website at www.alexotherapeutics.com

ALX Oncology Alternatives

Frequently Asked Questions about ALX Oncology

What is ALX Oncology email format?

The widely used ALX Oncology email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is ALX Oncology customer service number?

To contact ALX Oncology customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more